N/A
Completed N=120
Performance of Contour Next® and Contour Plus Elite® BGMS in Arterial Blood Samples From Hospitalized Adults
Source: ClinicalTrials.gov NCT05449795 ↗Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcomePrimary: Number of Results From the Contour Next BGMSs Reference Values Within ±12.5% of Reference Values — 236 blood samples
Summary
The purpose of the study is to extend the intended use of two BGMSs to include testing of arterial blood by Health Care Professionals (HCP) in a clinical setting.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Results From the Contour Next BGMSs Reference Values Within ±12.5% of Reference Values |
236 | — |
| PRIMARY Number of Results From the Contour Plus Elite BGMSs Reference Values Within ±12.5% of Reference Values |
240 | — |
Eligibility Criteria
Inclusion Criteria
- Patients who are at least 18 years old.
- Residual Arterial blood samples collected from subjects hospitalized in a Critical Care Unit (medical and surgical intensive care units (ICUs)).
- Sample blood volume must be sufficient to complete investigational testing procedures clinical laboratory testing.
Exclusion Criteria
- Residual arterial blood samples collected from subjects previously enrolled. and evaluated for this study.
Data sourced from ClinicalTrials.gov (NCT05449795). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.